Connect
MJA
MJA

Australia needs a better system for health care evaluation

Fiona J Stanley and Eric M Meslin
Med J Aust 2007; 186 (5): 220-221.
Published online: 5 March 2007

Is it unethical to avoid using all available information to monitor drug safety?

Adverse effects of health care have recently been in the news, from the worrying unexpected cardiovascular risks associated with use of the cyclooxygenase-2 inhibitor rofecoxib (Vioxx) to reports of high percentages of complications following routine surgery.1,2 As medical care becomes more complex, sophisticated and expensive in Australia, it is paramount that we have the best systems in place to monitor its impact and evaluate its safety and efficacy.

  • Fiona J Stanley1
  • Eric M Meslin2

  • 1 Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, WA.
  • 2 Indiana University, Indianapolis, Ind, USA.

Correspondence: fiona@ichr.uwa.edu.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.